This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Arigita, C. Articles by Jiskoot, W. Search for Related Content PubMed PubMed Citation Articles by Arigita, C. Articles by Jiskoot, W.

 Previous Article  |  Next Article 

Infection and Immunity, September 2003, p. 5210-5218, Vol. 71, No. 9
0019-9567/03/$08.00+0     DOI: 10.1128/IAI.71.9.5210-5218.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Liposomal Meningococcal B Vaccination: Role of Dendritic Cell Targeting in the Development of a Protective Immune Response

Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University,¹ Immunotherapy Laboratory, Department of Immunology, University Medical Center Utrecht, Utrecht,³ Laboratory for Product and Process Development, Netherlands Vaccine Institute, Bilthoven, The Netherlands²

Received 14 March 2003/ Returned for modification 1 May 2003/ Accepted 20 June 2003

The effect of targeting strategies for improving the interaction of liposomal PorA with dendritic cells (DC) on the immunogenicity of PorA was investigated. PorA, a major antigen of Neisseria meningitidis, was purified and reconstituted in different types of (targeted) liposomes, i.e., by using mannose or phosphatidylserine as targeting moieties, or with positively charged liposomes. We studied the efficiency of liposome uptake and its effect on the maturation of and interleukin 12 (IL-12) production by murine DC. Moreover, mice were immunized subcutaneously to study the localization and immunogenicity of PorA liposomes. Uptake of liposomes by DC was significantly increased for targeted liposomes and resulted in the maturation of DC, but to various degrees. Maturation markers (i.e., CD80, CD86, major histocompatibility complex class II, and CD40) showed enhanced expression on DC incubated with targeted PorA liposomes relative to those incubated with nontargeted PorA liposomes. Moreover, only the uptake of targeted PorA liposomes induced production of IL-12 by DC, with levels similar to those produced by lipopolysaccharide (LPS)-pulsed DC. Mannose-targeted PorA liposomes administered subcutaneously had an increased localization in draining lymph nodes compared to nontargeted PorA liposomes. Liposomes in draining lymph nodes interacted preferentially with antigen-presenting cells, an effect that was enhanced with targeted PorA liposomes. Immunization studies showed an improvement of the bactericidal antibody response (i.e., increased number of responders) generated by targeted PorA liposomes compared to that generated by nontargeted ones or LPS-containing outer membrane vesicles. In conclusion, the use of targeted PorA liposomes results in an improved uptake by and activation of DC and an increased localization in draining lymph nodes. These effects correlate with an enhanced immune response toward the vaccine.

Editor: J. N. Weiser

This article has been cited by other articles:

• Lam, J. S., Mansour, M. K., Specht, C. A., Levitz, S. M. (2005). A Model Vaccine Exploiting Fungal Mannosylation to Increase Antigen Immunogenicity. J. Immunol. 175: 7496-7503 [Abstract] [Full Text]  
• Hutchings, C. L., Gilbert, S. C., Hill, A. V. S., Moore, A. C. (2005). Novel Protein and Poxvirus-Based Vaccine Combinations for Simultaneous Induction of Humoral and Cell-Mediated Immunity. J. Immunol. 175: 599-606 [Abstract] [Full Text]